Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones
US11261192B2 · kind B2 · utility
1Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2019 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Feb 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.